市場調查報告書

全球風濕治療藥市場規模調查:各疾病類型,各藥物類型,各銷售管道,及各地區預測

Global Rheumatology Therapeutics Market Size study, by Disease Type, by Drug Type, by Distribution Channel and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 876670
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球風濕治療藥市場規模調查:各疾病類型,各藥物類型,各銷售管道,及各地區預測 Global Rheumatology Therapeutics Market Size study, by Disease Type, by Drug Type, by Distribution Channel and Regional Forecasts 2019-2026
出版日期: 2019年06月25日內容資訊: 英文
簡介

這份報告提供全球風濕治療藥市場的相關調查、 提供市場機會,各疾病類型·藥物類型·通路·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

第1章 摘要整理

  • 市場概述
  • 主要趨勢
  • 整體及各分類市場預測
    • 各疾病類型
    • 各藥物類型
    • 各銷售管道
    • 各地區
  • 調查方法
  • 調查的前提條件

第2章 風濕治療藥市場定義和範圍

  • 研究的目的
  • 市場定義和範圍
    • 產業的演進
    • 調查範圍
  • 研究涵蓋年份
  • 貨幣比率

第3章 風濕治療藥市場動態

  • Seesaw分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 風濕治療藥市場產業分析

  • 波特的五力分析
    • 買主談判力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業內的競爭
    • 波特五力分析的未來性方法
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
  • 主要的購買標準(隨選)
  • 法律規範(隨選)
  • 投資/引進方案(隨選)
  • 分析師的建議與結論

第5章 風濕治療藥市場:各疾病類型

  • 市場概述
  • 市場實際成果 - 潛在力模式
  • 主要市場參與企業
  • 風濕治療藥市場,子區隔分析
    • 慢性風濕病
    • 僵直性脊椎炎
    • 骨關節炎
    • rupusu
    • 痛風
    • 其他

第6章 風濕治療藥市場:各藥物類型

  • 市場概述
  • 市場實際成果 - 潛在力模式
  • 主要市場參與企業
  • 風濕治療藥市場,子區隔分析
    • 非類固醇系抗發炎藥(NSAID)
    • 止痛藥
    • 緩解疾病性抗風濕藥(DMARD)
    • 皮質類固醇
    • 其他

第7章 風濕的治療藥市場:各銷售管道

  • 市場概述
  • 市場實際成果 - 潛在力模式
  • 主要市場參與企業
  • 風濕治療藥市場,子區隔分析
    • 零售藥局
    • 線上藥局
    • 醫院
    • 其他

第8章 風濕治療藥市場:各地區

  • 風濕治療藥市場,地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 其他的歐洲
  • 亞洲
    • 中國
    • 印度
    • 日本
    • 其他的亞太地區
  • 南美
    • 巴西
    • 墨西哥
  • 世界其他地區的地區
    • 南美
    • 中東及非洲

第9章 競爭情形

  • 企業的市場佔有率(視資料情況而定)
  • 首位市場策略
  • 企業簡介
    • AbbVie
    • Pfizer
    • Bristol-Myers Squibb Company
    • Merck & Co.
    • Amgen
    • Janssen Biotech
    • Novartis AG
    • Genentech
    • 武田藥品工業株式會社
    • Sanofi

第10章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件
目錄

Global Rheumatology Therapeutics Market valued approximately USD 44.38 billion in 2018 is anticipated to grow with a healthy growth rate of more than 2.73% over the forecast period 2019-2026. The Rheumatology Therapeutics Market is continuously growing in the global scenario at significant pace. Rheumatology therapeutics market consists of therapeutics used for the treatment of rheumatic disorders, which include rheumatoid arthritis, juvenile rheumatoid arthritis, spondylarthritis, systemic lupus erythematosus, and systemic sclerosis. It is also associated with pain disorders in joints, ligaments and muscles. Rising incidence of rheumatology diseases, rising geriatric population worldwide are the substantial driving factors of the market during the forecast period. Additionally, increasing awareness regarding diseases remittances therapies and growing healthcare expenditure are another factor that impelling the demand of rheumatology therapeutics across the globe. Moreover, technological advancements in pharmaceutical field and increasing investments in healthcare industry for research and development activities are the factors that likely to create numerous opportunity in the near future. However, high capital investment in drug development and presence of alternative such as biosimilar are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Rheumatology Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to rising geriatric population, growing healthcare expenditure and high adoption of biopharmaceuticals for the treatment in the region. Europe is estimated to grow at significant growth rate in the global Rheumatology Therapeutics market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to increasing prevalence of rheumatology diseases and rising number of patient population across the region.

The major market player included in this report are:

AbbVie

Pfizer

Bristol-Myers Squibb Company

Merck & Co.

Amgen

Janssen Biotech

Novartis AG

Genentech

Takeda Pharmaceutical

Sanofi

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Rheumatoid Arthritis

Ankylosing Spondylitis

Osteoarthritis

Lupus

Gout

Others

By Drug Type:

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Analgesics

Disease Modifying Anti-Rheumatic Drugs (DMARDs)

Corticosteroids

Others

By Distribution Channel:

Retail Pharmacy

Online Pharmacy

Hospitals

Others

By Regions:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017

Base year - 2018

Forecast period - 2019 to 2026

Target Audience of the Global Rheumatology Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Rheumatology Therapeutics Market, by Disease Type, 2016-2026 (USD Billion)
    • 1.3.2. Rheumatology Therapeutics Market, by Drug Type, 2016-2026 (USD Billion)
    • 1.3.3. Rheumatology Therapeutics Market, by Distribution Channel, 2016-2026 (USD Billion)
    • 1.3.4. Rheumatology Therapeutics Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Rheumatology Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Rheumatology Therapeutics Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Rheumatology Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Rheumatology Therapeutics Market, by Disease Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Rheumatology Therapeutics Market, Sub Segment Analysis
    • 5.4.1. Rheumatoid Arthritis
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Ankylosing Spondylitis
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Osteoarthritis
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.4. Lupus
      • 5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.5. Gout
      • 5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Rheumatology Therapeutics Market, by Drug Type

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Rheumatology Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Analgesics
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.3. Disease Modifying Anti-Rheumatic Drugs (DMARDs)
      • 6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.4. Corticosteroids
      • 6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Rheumatology Therapeutics Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Rheumatology Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Retail Pharmacy
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. Online Pharmacy
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Hospitals
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Rheumatology Therapeutics Market, by Regional Analysis

  • 8.1. Rheumatology Therapeutics Market, Regional Market Snapshot (2016-2026)
  • 8.2. North America Rheumatology Therapeutics Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.4. Distribution Channels breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.3. Europe Rheumatology Therapeutics Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.3. Rest of Europe
      • 8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.4. Asia Rheumatology Therapeutics Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.5. Latin America Rheumatology Therapeutics Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.6. Rest of The World
    • 8.6.1. South America
      • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.6.2. Middle East and Africa
      • 8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. AbbVie
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. Pfizer
    • 9.3.3. Bristol-Myers Squibb Company
    • 9.3.4. Merck & Co.
    • 9.3.5. Amgen
    • 9.3.6. Janssen Biotech
    • 9.3.7. Novartis AG
    • 9.3.8. Genentech
    • 9.3.9. Takeda Pharmaceutical
    • 9.3.10. Sanofi

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
    • 10.1.6. Research Assumption

List of Tables

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF RHEUMATOLOGY THERAPEUTICS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF RHEUMATOLOGY THERAPEUTICS MARKET
  • TABLE 3. RHEUMATOLOGY THERAPEUTICS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISEASE TYPE 2016-2026 (USD BILLION)
  • TABLE 8. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DRUG TYPE 2016-2026 (USD BILLION)
  • TABLE 9. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2016-2026 (USD BILLION)
  • TABLE 10. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. RHEUMATOLOGY THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. U.S. RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. CANADA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. UK RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. GERMANY RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 67. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. ROE RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 72. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. CHINA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 77. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. INDIA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. JAPAN RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. ROAPAC RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. BRAZIL RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. MEXICO RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 102. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROLA RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 107. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 108. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 110. ROW RHEUMATOLOGY THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

List of Figures

  • FIG 1. RHEUMATOLOGY THERAPEUTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. RHEUMATOLOGY THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. RHEUMATOLOGY THERAPEUTICS MARKET, KEY TRENDS 2017
  • FIG 5. RHEUMATOLOGY THERAPEUTICS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. RHEUMATOLOGY THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. RHEUMATOLOGY THERAPEUTICS MARKET, PEST ANALYSIS
  • FIG 8. RHEUMATOLOGY THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. RHEUMATOLOGY THERAPEUTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. RHEUMATOLOGY THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 33. EUROPE RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 34. ASIA PACIFIC RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 35. LATIN AMERICA RHEUMATOLOGY THERAPEUTICS MARKET 2016 & 2026 (USD BILLON)
  • FIG 36. RHEUMATOLOGY THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)
Back to Top